Bitcoin Tops $29,000; Render Token Emerges As Top Gainer

Bitcoin (CRYPTO: BTC) moved higher, with the cryptocurrency prices trading above the key $29,000 level on Friday. Ethereum (CRYPTO: ETH) also recorded gains, trading above the key $1,900 mark this morning.

Bitcoin (CRYPTO: BTC) moved higher, with the cryptocurrency prices trading above the key $29,000 level on Friday.

Ethereum (CRYPTO: ETH) also recorded gains, trading above the key $1,900 mark this morning.

Render Token (CRYPTO: RNDR) was the top gainer over the prior 24 hours, while MultiversX (CRYPTO: EGLD) turned out to be the biggest loser.

At the time of writing, the global crypto market cap rose to $1.21 trillion, recording a 24-hour gain of 1.2%. BTC was trading higher by 2% at $29,335 while ETH rose by around 2% to $1,906 on Friday.

Here are the top ten crypto gainers and losers over the past 24 hours:

Gainers

  • Render Token (CRYPTO: RNDR)

Price: $2.51
24-hour gain: 11.1%

  • Internet Computer (CRYPTO: ICP)

Price: $6.03
24-hour gain: 10.7%

  • PancakeSwap (CRYPTO: CAKE)

Price: $2.78
24-hour gain: 7.5%

  • Immutable (CRYPTO: IMX)

Price: $1.07
24-hour gain: 6.5%

  • Solana (CRYPTO: SOL)

Price: $22.65
24-hour gain: 4.9%

Losers

  • MultiversX (CRYPTO: EGLD)

Price: $43.89
24-hour drop: 3%

  • Frax Share (CRYPTO: FXS)

Price: $8.07
24-hour drop: 2.4%

  • BNB (CRYPTO: BNB)

Price: $323.26
24-hour drop: 2%

  • Stacks (CRYPTO: STX)

Price: $0.7215
24-hour drop: 2%

  • Monero (CRYPTO: XMR)

Price: $153.79
24-hour drop: 1.5%

Read This Next: Mastercard To Rally Over 18%? Here Are 10 Other Analyst Forecasts For Friday

Total
0
Shares
Related Posts
Read More

Immutep Announced New Patent Granteds in Japan and South Korea for First-in-Class LAG-3 Candidate, Eftilagimod Alpha in Chemo-Immunotherapy Combination

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease, is pleased to announce the grant of two new patents (numbers 7160345 and 10- 2441425) entitled "Combined Preparations for the Treatment of Cancer" by the Japanese Patent Office and South Korean Patent Office, respectively

IMMP

Read More

A Fed Rate Hike Is All But Certain This Week: 2 Phrases In The FOMC Statement May Be What Moves The Market

The Federal Open Market Committee (FOMC) is widely expected to issue at least one more 0.25% interest rate hike at the conclusion of its meeting on Wednesday. The rate hike itself will likely not move financial markets much, but the language the FOMC uses in its policy statement could be a major catalyst.

SPY